Nanocarriers for Targeted Therapy and Management of Ovarian Cancer

Nanocarriers for Targeted Therapy and Management of Ovarian Cancer provides a comprehensive and up-to-date overview of nanomedicine strategies for improving ovarian cancer treatment. The book examines diverse nanocarrier platforms, including liposomes, solid lipid nanoparticles, polymeric nanoparticles, micelles, dendrimers, mesoporous silica nanoparticles, niosomes, nanogels, hydrogels, and exosome-based systems. It integrates advances in targeted and controlled drug delivery with tumor biology, pharmacokinetics, safety, regulatory considerations, artificial intelligence, and clinical translation. By bridging fundamental science and clinical applications, this multidisciplinary resource highlights emerging technologies, therapeutic challenges, and future opportunities for researchers, oncologists, pharmaceutical scientists, and students.

• Provides cancer-specific chapters detailing advanced nanocarrier-based therapeutic delivery approaches
• Covers targeted and controlled drug delivery strategies for ovarian cancer management
• Integrates nanomedicine with clinical translation, safety, and regulatory considerations
• Explores emerging AI-driven and exosome-based nanocarrier technologies
• Bridges nanotechnology, pharmaceutical sciences, and clinical oncology for precision therapy